Effects of induction of ovulation with GnRH or HCG on follicular and luteal blood flow in Holstein-Friesian heifers

The objective of this study was to compare the effects of gonadotropin-releasing hormone (GnRH) and human chorionic gonadotropin (hCG) on follicular blood flow (FBF) during the pre-ovulatory period and on luteal blood flow (LBF) during dioestrus in Holstein-Friesian heifers. Twelve animals were randomly divided into two groups and treated with either intramuscular injection of 100 μg GnRH or intravenous (IV) injection of 5000 IU hCG on Day 0 (oestrus, 48 h after administration of PGF(2α) ) to induce ovulation. Follicular size (FS), FBF and time of ovulation were recorded with colour Doppler sonography at 0, 1, 3, 6, 12 and 24 h after GnRH and hCG treatment. Luteal size (LS) and LBF were investigated on Day 9 and 12 after ovulation. Plasma samples were taken to determine total oestrogens (E(tot) ) and progesterone (P(4) ) after each examination. Ovulation occurred between 24 and 48 h after treatment in all animals. No difference (p > 0.05) was observed in FS between the two treatment groups. Follicular blood flow was higher in the hCG group than that was in GnRH group at 1 h after treatment (p < 0.01). Total oestrogens were also higher (p < 0.01) in the hCG group than GnRH group; however, this difference was only obvious at 12 h after treatment. No difference (p > 0.05) was observed in LS, LBF or P(4) levels on Day 9 and 12 between treatment groups. In conclusion, the results suggest that induction of ovulation with hCG and GnRH has a temporary effect on FBF and oestrogen levels while no effect on the size of corpora lutea, LBF and P(4) levels was observed.     

Comparison of HCG, buserelin and luprostiol for induction of ovulation in cycling mares

Sixty nonlactating light-horse mares were used to compare the efficacy of hCG, buserelin (a GnRH analog) and luprostiol (a PGF₂α analog) for induction of ovulation in cycling mares. Mares were assigned to 1 of 4 treatments: 1) controls; 2) 40 μg buserelin IM at 12 hr intervals during estrus until ovulation; 3) 7.5 mg IM luprostiol; and 4) 3,300 IU hCG. Treatments were given once a mare obtained a ≥35mm follicle and had been in estrus ≥2 days. Both buserelin and hCG shortened (p<0.05) the interval from treatment to ovulation compared to controls; whereas, luprostiol failed to hasten ovulation. Number of follicles ovulated was similar among all 4 groups. Although buserelin and hCG were equal in their ability to induce ovulation, an average of 3.8 injections of buserelin was required for hastening of ovulation.     

The course of ovulation in gilts after the partial replacement of HCG by GnRH for ovulation stimulation

The ovulation status and the amount of ovulated follicles were determined in 3 experiments from 197 gilts which had been given differentiated treatment and which were subsequently slaughtered. Ovulation stimulation produced high synchronisation effects, as compared to untreated animals. Partial substitution proved possible of Gn-RH vet. "Berlin-Chemie" for 500 I.U. of HCG which were generally used to stimulate ovulation, since the amount of ovulated follicles 169 hours from the last application of Suisynchron premix was in all 3 cases above the specified value of 85.0 per cent even after injection of 300 I.U. HCG/300 micrograms Gn-RH.     

Timing of induction of ovulation in mares treated with Ovuplant or Chorulon

Reliable induction of timed ovulation is an important managerial tool in any horse-breeding operation. Not only does breeding close to ovulation increase pregnancy rates when using cooled, frozen, or poor-quality semen, but it also reduces the number of inseminations needed per cycle, resulting in a more efficient breeding program. To better predict ovulation time in the long estrus period of the mare, one could increase the frequency of transrectal palpations and ultrasounds and/or implement hormonal therapies to induce ovulations. However, previous studies have been unclear on the exact timing of ovulation of mares treated with human chorionic gonadotropin (Chorulon, Intervet Inc, Millsboro, DE) or deslorelin acetate (Ovuplant, Pharmacia and UpJohn Co, Kalamazoo, MI). This study was designed to determine the timing of ovulation after Ovuplant or Chorulon treatment in normal cycling mares presented to the veterinary clinic. In addition, the pregnancy rates were determined for mares bred when a single insemination, using frozen or chilled semen, was performed at a fixed time (36 hours) after Ovuplant or Chorulon treatment. Thirty-two mares were given a subcutaneous injection of 7.5 mg of prostaglandin F2α (Lutlyse, Ft Dodge Animal Health, Ft Dodge, IA) 5 days after the last ovulation and were examined every 48 hours until estrus was detected based on a dominant follicle and the presence of endometrial edema as determined by ultrasonographic examination. Group 1 (N = 12) was treated intravenously with 2,500 units of Chorulon, and group 2 (N = 20) was treated subcutaneously with Ovuplant as soon as mares were determined to be in estrus. Once treated all mares were examined by rectal palpation and ultrasound at 0, 12, 24, 28, 30, 32, 34, 36, 38, 40, 42, 44, 48, 60, 72, 84, 96, hours or until ovulation was detected. Ovulation rate in response to Chorulon was 83.3% at 48 hours, 91.6% at 72 hours, and 100% at 96 hours. All of the mares in the Ovuplant-treated group had ovulated by 48 hours. Chi-square analysis of the data showed a significant (P < .01) variation in the distribution of ovulation times between mares treated with Chorulon and mares treated with Ovuplant. This study provides enough evidence to support the hypothesis that timing of ovulation is a more reliable event in mares treated with Ovuplant compared with those treated with Chorulon.     

The effect of various doses HCG on ovulation stimulation in gilts following previous biotechnical puberty induction

The effects of various doses of human chorionic gonadetropine (HCG) to stimulate ovulation in 86 gilts in which puberty had been induced by administration of 500 IU of pregnant mare serum (PMS) and 250 IU of HCG were established by slaughter. Only 26.9 per cent of the group without HCG had completed ovulation 120 hours from puberty induction, but 93.5 per cent had done so in the group which had received additional 500 IU or HCG 78 hours after the PMS/HCG injection. Ovulation was completed by 71.4 per cent of those sows which had been stimulated, using 250 IU of HCG. More accurate timing of ovulation in animals of one and the same group can be helpful in better insemination timing.     

Follicular dynamics after treatment with hCG for ovulation induction in mares

In this study the use of hCG for induction of ovulation is described. Factors such as follicle diameter at the time of administration of hCG (3000 IE hCG i.v.), follicular growth after hCG and the rate of double ovulations were evaluated. A total of 168 mares presented for artificial insemination were used. In 249 estrous periods hCG was given to mares exhibiting standing estrous when a minimum follicle diameter of 30 mm and a well developed edema of the endometrium could be detected by ultrasonography. In nine estrous periods ovulation occurred within 24 hours after hCG. The majority of mares (216; 86.7%) ovulated 24 to 48 hours after hCG and in 24 cases ovulation was delayed beyond 48 hours. Follicle size at the time of hCG administration (30-34 mm, 35-39 mm, > or = 40 mm) had no influence on the percentage of mares ovulating 24 to 48 hours after hCG (89.2%, 87.9%, and 83.7%, respectively). Double ovulations could be observed in 17.7% of estrous periods. The one cycle pregnancy rate was not influenced by follicle size (small 45.9%; medium 41.6%; large 47.5%). Repeated treatments with hCG during successive estrous cycles within one year did not influence the rate of responding to hCG. Mares in standing estrous respond well to hCG if a minimum follicle size of 30 mm and a well developed endometrial folding is present.     

Reproductive performance of Thoroughbred mares on six commercial stud farms

The records of 1630 mare years from 6 Thoroughbred stud farms in south eastern Australia were analysed for the years 1981 to 1986. Overall pregnancy and foaling rates were 83.9% and 69.3%, respectively. When calculated per served oestrous cycle, pregnancy and foaling rates were 54.7% and 43.1%, respectively. Pregnancy and foaling rates were higher (P < 0.001) for mares 3 to 10 years of age than for older mares. There was no difference in the pregnancy rates of maiden, barren and foaling mares. The foaling rate was significantly higher (P < 0.001) in mares that became pregnant during the first served oestrous cycle (77.8%) than in mares that needed two served oestrous cycles to become pregnant (65.4%). Of all diagnosed pregnancies, 19.5% were not completed. Pregnancy loss was lower (P < 0.05) in maiden (12.4%) than in barren (19.7%) or foaling (20.9%) mares. Twins were diagnosed in 7.8% of all pregnancies. If one conceptus was lost without external interference, 84.1% of pregnancies went to term. If one conceptus was manually crushed, 55.9% of pregnancies were maintained. If prostaglandin was used to terminate twin pregnancies, 60% of mares so treated produced foals the following year.     

Clinical experience with deslorelin (ovuplantTM) in a kentucky thoroughbred broodmare practice (1999)

Palpation records of 155 Throughbred broodmares maintained on one of seven farms (3–80 mares per farm) that were administered deslorelin on one or more estrous cycles (204 treated cycles) during the 1999 breeding season were retrospectively examined. Some deslorelin-treated mares were also treated with hCG (2500 units intravenously), or had no ovulation-inducing drugs administered, during different estrous cycles of the same season. Most mares were treated with an ovulation- inducing drug after returning to their resident farm following breeding and were subsequently examined by transrectal ultrasonography daily until ovulation was confirmed, and again 13–14 and 15–16 days after ovulation for determination of pregnancy status.Per-cycle pregnancy rate for all 155 mares bred was 53%, and for all deslorelin breeding was 57%. Per-cycle pregnancy rates for mares ovulating 0–1 days, 1–2 days, and 2–3 days after treatment with deslorelin did not differ (P>0.05). Forty-six mares received more than one treatment during the breeding season, yielding 115 breedings (estrous cycles) for comparison of pregnancy rates among treatment. Per-cycle pregnancy rates for these mares did not differ among treatments (P>0.10).No differences due to treatment were detected in mean interval to ovulation (P>0.10). Mean interovulatory interval was longer for deslorelin-treated mares than for untreated or hCG treated mares (P>0.01). Eighty percent (80%) of deslorelin-treated mares had interovulatory intervals of 18–25 days, and 19% had interovulatory intervals>25 days. Ninety-seven percent (97%) of untreated or hCG-treated mares had interovulatory interovulatory intervals>25 days. More deslorelin-treated mares had extended (>25 days) interovulatory intervals than hCG- or nontreated-mares (P>0.05). In this group of Thoroughbred mares, it appeared that season (month) and management (farm) factors had only minor effects on the incidence of extended interovulatory intervals following use of deslorelin.     

Comparision of ovulation synchronization (OVSYNCH) with the selective induction of oestrus using PGF2alpha after rectal palpation in a dairy herd

The efficacy of a protocol for the synchronization of ovulation followed by timed Al (OVSYNCH) was compared with a reproductive management protocol based on induction of oestrus after rectal palpation using PGF2alpha on a commercial dairy farm in Brandenburg, Germany. Cows in the OVSYNCH group (n = 309) were treated between 62 and 68 days in milk (DIM) with 0.02 mg of buserelin (GnRH analogue) intramuscularly (i.m.). Seven days later 0.75 mg of tiaprost (PGF2alpha-analogue) were administered i.m. to regress the corpus luteum (C.I.). All cows received a second treatment with GnRH another 48 hrs later and were inseminated 16 to 20 hrs after the second GnRH-treatment (72 to 78 DIM). Cows in the PGF group (n = 302) were examined by rectal palpation between 69 and 75 DIM. Cows with a C.I. received 0.75 mg of tiaprost to induce oestrus. Cows were inseminated on observed oestrus. Cows not inseminated within 14 days after treatment were re-examined between 83 and 89 DIM. For both groups, the voluntary waiting period was set at 72 DIM. Service rate was higher (86.4 vs. 63.2 %, P < 0.05), days to first service (77 +/- 11 vs. 86 +/- 19 days, P < 0.001) and days open (102 +/- 34 vs. 109 +/- 35 days, P < 0.05) were shorter in the OVSYNCH group. First service conception rate (40.3 vs. 42.4 %), conception rate to all services (37.9 vs. 40.0 %) and the proportion of pregnant cows at 200 DIM were similar in the OVSYNCH evaluation for the total costs per pregnancy in 71 different cost scenarios showed only slight differences between the groups. Mean costs per pregnancy were euro 235.43 and euro 235.08 for the OVSYNCH and the PGF group, respectively. Quality of oestrus as assessed by the Al technician did not reveal a relationship to conception rate after OVSYNCH and timed Al. However, swelling, hyperaemia and a moist vestibulum were positively associated with conception rate.     

Synchronizing estrus and(or) ovulation in beef cows after combinations of GnRH, norgestomet, and prostaglandin F2alpha with or without timed insemination

Three experiments were conducted to induce estrus and(or) ovulation in 1,590 suckled beef cows at the beginning of a spring breeding season. In Exp. 1, 890 cows at three locations were allotted to three treatments: 1) GnRH on d -7 + prostaglandin F2alpha (PGF2alpha) on d 0 (Select Synch); 2) GnRH on d -7 + PGF2alpha on d 0 (first day of the breeding season) plus a norgestomet implant (NORG) between d -7 and 0 (Select Synch + NORG); or 3) two injections of PGF2alpha given 14 d apart (2xPGF2alpha). More (P < 0.05) cycling cows were detected to have been in estrus after both treatments that included GnRH, whereas, among noncycling cows, the addition of norgestomet further increased (P < 0.05) the proportion in estrus. Pregnancy rates were greater (P < 0.01) among noncycling cows after treatments that included GnRH. For cows that calved >60 d before the onset of the breeding season, conception rates were greater (P < 0.01) than those that calved < or =60 d regardless of treatment, whereas days postpartum had no effect on rates of detected estrus. When body condition scores were < or =4 compared with >4, rates of detected estrus (P < 0.05) and conception (P = 0.07) were increased. In Exp. 2, 164 cows were treated with the Select Synch + NORG treatment and were inseminated either after estrus or at 16 h after a second GnRH injection (given 48 h after PGF2alpha). Conception and pregnancy rates tended (P = 0.08) to be or were less (P < 0.05), respectively, for noncycling cows inseminated by appointment, but pregnancy rates exceeded 53% in both protocols. In Exp. 3, 536 cows at three locations were treated with the Select Synch protocol as in Exp. 1 and inseminated either: 1) after detected estrus (Select Synch); 2) at 54 h after PGF2alpha when a second GnRH injection also was administered (Cosynch); or 3) after detected estrus until 54 h, or in the absence of estrus, at 54 h plus a second GnRH injection (Select Synch + Cosynch). Conception rates were reduced (P < 0.01) in cows that were inseminated by appointment. An interaction of AI protocol and cycling status occurred (P = 0.05) for pregnancy rates with differing results for cycling and noncycling cows. Across experiments, variable proportions of cows at various locations (21 to 78%) were cycling before the breeding season. With the GnRH or GnRH + NORG treatments, ovulation was induced in some noncycling cows. Conception rates were normal and pregnancy rates were greater than those after a PGF2alpha program, particularly when inseminations occurred after detected estrus.